Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preference information – what it what it not
… Health Preference Assessment Do you know what your patients value and what they would be willing to … to get what is important to them? For example, if your patient has to choose between a highly effective drug with a …
… Discovering What Treatment Options are Most Important to Patients With … core outcome set and input from clinical experts, a patient living with PsA, and patient advocates. The survey … that included methotrexate, and for those reporting a preference, the reasons behind their preferences. Study …
… most. Researchers with RTI Health Solutions conducted a patient-preference study using a discrete-choice experiment survey to elicit this information. The primary objectives were to quantify patient …
… product’s treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated using a number of stated-preference methods including discrete-choice experiments and … monetary measure of benefit and can answer questions like what’s it worth to a patient if: The dosing regimen changes …
… relevant support and advice. We can help you understand what RWE guidelines mean for your medical product research … program—from market access, outcomes research, patient preference, and economic evaluation, to reimbursement and …
… GVDs present evidence-based messages that demonstrate what your new product brings to the market and how it will be positioned relative to other products. Information is presented so that all users are able to access … help answer. Key Factors Key Questions About Your Product Patient Perspective Can I afford it? Is it easy for me to …
… experiences and outcomes . If it does not, critical information needed to address health disparities could be … address health outcomes for historically marginalized patient populations, researchers and care providers need to … in patient centered drug development with patient preference research . Poulos C , Mansfield C , Bussberg …
… Joint Clinical Assessments: Racing to the Finish Line at What Cost? Share on: July 29, 2024 Contributed by: Emma … PICO scoping process. That means they may not have enough information up front to adequately prepare for the JCA. The … questions and additional information requests. It also leaves little time to perform factual checking of the …
… Benefit-Risk Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are used to determine how your … the relative importance of benefits and risks and a patient’s maximum acceptable risk (MAR). If the actual risk …
… the drug development process. The Alzheimer’s Disease Patient and Caregiver Engagement (AD PACE) initiative is a … with Alzheimer’s and their caregivers and to use that information to develop treatments that can help improve … Brett Hauber, PhD, Senior Economist and VP of Health Preference Assessment at RTI-HS, will lead the AD PACE What …